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Abstract
Background: HbA1c has been the gold standard for glycaemic control follow-up for decades. In 2009, a level of 6.5%
(48 mmol/mol) was proposed as diagnostic for diabetes. We test this cut-off in our community.
Methods: Participants (946) from a community-based study were screened for diabetes using either a fasting blood glucose
or oral glucose tolerance test (OFTT). The HbA1c cut-off of 6.5% was tested for each group. A receiver operator characteristic
(ROC) curve for both groups was generated to establish an optimal cut-off.
Results: Our study included 224 (23.7%) males and 722 (76.3%) females. Using fasting blood glucose alone, 117 (14%) were
diagnosed with diabetes 250% had an HbA1c value of $6.5% (48 mmol/mol). Using an OGTT, 147 (18%) were diagnosed
with diabetes 246% had an HbA1c value of $6.5% (48 mmol/mol). ROC curves found a level of 6.1% (43 mmol/mol) to be
optimal in both groups (AUC 0.85 and 0.82 respectively). The sensitivities were 80% and 75% and the specificities 77% and
78% respectively.
Conclusions: A cut off of 6.5% (48 mmol/mol) is a good diagnostic tool with its high specificity; however the low sensitivity
limits its use. We found a level of 6.1% (43 mmol/mol) to be optimal. This emphasizes the need for evidenced based values
to be established in various population groups.
Citation: Zemlin AE, Matsha TE, Hassan MS, Erasmus RT (2011) HbA1c of 6.5% to Diagnose Diabetes Mellitus—Does It Work for Us?—The Bellville South Africa
Study. PLoS ONE 6(8): e22558. doi:10.1371/journal.pone.0022558
Editor: Jose A. L. Calbet, University of Las Palmas de Gran Canaria, Spain
Received April 4, 2011; Accepted June 27, 2011; Published August 12, 2011
Copyright:  2011 Zemlin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by grants from the University Research Fund of the Cape Peninsula University of Technology, South Africa and the
National Health Laboratory Services South Africa (grant number 94122). The funders had no role in the study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rte@sun.ac.za
. These authors contributed equally to this work.
Introduction
Diabetes is a disease fuelled by the increasing worldwide obesity
epidemic with significant morbidity and mortality, and the World
Health Organization (WHO) estimates that it will affect 366
million individuals worldwide by 2030 [1]. Its diagnosis was
previously made either according to the WHO criteria which were
updated in 2006 [2] using a fasting blood glucose sample and
subsequent 75 g oral glucose tolerance test (OGTT) with blood
taken for glucose determination again 2 hours after an oral glucose
challenge, or according to the American Diabetes Association
(ADA) criteria which were updated in 2005 [3], using only a
fasting blood glucose level. Using ADA criteria only has been
found to underestimate the prevalence of diabetes and misses those
individuals with impaired glucose tolerance (IGT), a pre-diabetic
state [4]. The disadvantage of both these diagnostic approaches is
that they require the patient to fast and if need confirming, would
require a second fasting sample. Glucose also has a large biological
and diurnal variation and depends on recent carbohydrate intake
and the OGTT is fairly invasive [5]. In 2010, the ADA updated
their diagnostic criteria to include an OGTT as well [6].
On the other hand, HbA1c, which is formed by the attachment
of glucose to various amino groups of haemoglobin and has been
used since 1977 for the long-term (2–3 month) glycaemic control
follow up of diabetes, has recently been advocated by the ADA as
a diagnostic tool. In 2009, the International Expert Committee of
the ADA issued a statement proposing an HbA1c value of 6.5%
(48 mmol/mol) as a diagnostic level for the diagnosis of diabetes.
This value was chosen, as it was found to be the value after which
the incidence of retinopathy, a common complication that often is
present before the actual diagnosis of diabetes is made, is increased
[7]. This test would be advantageous, as it does not require a
fasting sample and has much less intraindividual variation.
The worldwide diabetes ‘‘epidemic’’ is expected to affect
developing countries more than developed ones. Studies to
determine the usefulness of HbA1c as a diagnostic tool in these
populations are needed, as there is a paucity of data from these
communities compared to Western countries. As there appear to
be racial differences in HbA1c levels [8,9], the purpose of this
study was to assess the utility of an HbA1c value of 6.5% as a
diagnostic tool for diabetes in our local Coloured (mixed ancestry)
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population, and to establish an optimum cut-off for this
population.
Results
A total of 946 subjects participated, comprising 642 random
subjects between the ages 35–65 years and 304 voluntary subjects,
age range 16–95. One hundred and twenty two subjects with
known diabetes and 5 that did not consent for blood collection
were excluded. Therefore, for this study, 819 subjects with the
median (confidence interval) age of 52 (52, 54) were eligible.
Table 1 shows the general characteristics of the participants for
this study. Although there were more females (722) than males
(224) in the cohort, this is not reflective of the female to male ratio
of the population, but of the willingness to participate. The females
had significantly higher BMI and subsequently a higher preva-
lence of diabetes mellitus. No significant differences were observed
between male and female HbA1c values; these ranged from 4.4%
(25 mmol/mol) to 13.3% (122 mmol/mol) (median 5.8%
(40 mmol/mol) and 5.9% (41 mmol/mol) respectively).
One hundred and seventeen subjects were newly diagnosed with
diabetes using fasting blood glucose and 147 when using an
OGTT. Using ROC curves, the optimal cut-off for HbA1c for
diabetes as diagnosed according to either fasting blood glucose or
OGTT gave a value of 6.1% (43 mmol/mol), AUC 0.85 and 0.82
respectively. The sensitivities at this cut-off were 80% and 75%
respectively and the specificities 77% and 78% respectively
(Figure 1). The ROC’s were repeated with age categories of
,60 and $60 years and the optimal cut-off for HbA1c as a
screening tool for diabetes remained at 6.1% (43 mmol/mol) for
both age categories.
Table 2 summarises the stratification of diabetic and normal
subjects according to HbA1c cut-off of 6.5% (48 mmol/mol) and
6.1% (43 mmol/mol). When using a cut-off of 6.5% as
recommended by the ADA, high specificities were obtained, but
sensitivity was sacrificed. An HbA1c value of 6.5% (48 mmol/mol)
gave a sensitivity of 50% and specificity of 95% using fasting blood
glucose for diagnosis and a sensitivity of 46% and specificity of
96% when using an OGTT.
Discussion
Type 2 diabetes is increasing in developing countries due to
growth and aging of the population, and urbanisation with its
introduction of an unhealthy diet and increasing obesity and
sedentary lifestyles. In a recent article Bradshaw et al estimated that
5.5% of all South Africans $30 years had diabetes [10]. Levitt et al
studied the prevalence of diabetes in 974 residents from the mixed
ancestry (coloured) community of Mamre, a rural town near Cape
Town in the Western Cape. The age standardized prevalence of
type 2 diabetes in the age group 30–65 years, South African mixed
ancestry population group was 10.8% and that of impaired glucose
tolerance (IGT) 10.2% [11]. Age, physical inactivity, family history
of diabetes and waist circumference was all identified as
independent risk factors [11]. Another study that specifically
examined the prevalence of diabetes in elderly coloured subjects
found a prevalence of 28% for men and 29% for women [12,13].
A population of Indian origin studied in sub-Saharan Africa found
prevalences of diabetes of between 12 and 13%. This increasing
Table 1. Characteristics of all participants (946), stratified by
gender.
Characteristics Male (N=224) Female (N=722) p
Age (years) 57 (44, 68) 53 (43, 64) 0.023
BMI (kg/m2) 25.1 (21.9, 29.2) 30.3 (25.8, 34.8) ,0.0001
FBG (mmol/L) 5.5 (5.0, 6.5) 5.6 (5.0, 6.4) 0.567
PostBG (mmol/L) 6.4 (5.3, 8.4) 6.9 (5.7, 8.9) 0.013
HbA1c (%) 5.9 (5.5, 6.3) 5.8 (5.5, 6.3) 0.856
FBG, fasting blood glucose; PostBG, post 2-hour blood glucose;
doi:10.1371/journal.pone.0022558.t001
Figure 1. ROC curves depicting an HbA1c cut-off value of 6.1%
as optimal for the diagnosis of DM according to fasting blood
glucose and the OGTT. Figure 1a area under curve = 0.85,
sensitivity = 80%, and specificity = 77%. Figure 1b area under
curve = 0.82, sensitivity = 75%, and specificity = 78%.
doi:10.1371/journal.pone.0022558.g001
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incidence of diabetes with its subsequent complications in Sub-
Saharan African countries such as South Africa places an even
greater burden on health care systems already buckling under the
challenges of diseases such as malaria, tuberculosis and HIV [14].
The incidence of diabetes in this study was more than 20% using
either fasting blood glucose or an OGTT for diagnosis. For this
reason, a quick and simple diagnostic test such as HbA1c would be
advantageous.
HbA1c is formed by the attachment of glucose to various amino
groups. The Diabetes Control and Complications Trial (DCCT),
which determined HbA1c using a precise HPLC method, showed
that a reduction of HbA1c led to a reduction in diabetic
complications [15]. This opened the door for HbA1c standard-
ization, as there are numerous analytical methods available for its
determination [16]. In 2009, the International Expert Committee
of the ADA issued a statement proposing an HbA1c value of 6.5%
(48 mmol/mol) as a diagnostic level for the diagnosis of diabetes.
This value was chosen, as it was found to be the value after which
the incidence of retinopathy, a common complication that often is
present before the actual diagnosis of diabetes is made, is increased
[7]. Westgard expressed concern about using the HbA1c value as
a diagnostic test, as even though the test has been ‘‘standardized’’,
CAP proficiency testing still shows significant biases between
methods [17].
Previous studies proposed using HbA1c as a screening tool for
the detection of diabetes, but their cut-off values differed [18–21].
In the present study, we have shown a cut-off of 6.1% (43 mmol/
mol) as optimal for all mixed ancestry ages groups from South
Africa. Our findings are similar to those reported by Bennett et al
who performed a meta-analysis of nine studies and found that
most recommended an HbA1c cut off of 6.1% (43 mmol/mol) as
optimal [19]. A recent study by Kumar et al assessed the validity of
HbA1c as a screening and diagnostic test for diabetes. They found
a value of 6.1% (43 mmol/mol) had optimal sensitivity and could
thus be used for screening and 6.5% to have optimal specificity
and could thus be used as a diagnostic test [21]. In 2008, Saudek et
al found an HbA1c cut off of 6.0% (42 mmol/mol) to be optimal
for screening and 6.5% (48 mmol/mol) for diagnosis of diabetes
[20]. Rowley et al found that a value of 7% (53 mmol/mol) had the
best specificity and could therefore be used as a diagnostic test.
However, this study was published in 2005 [18].
Our study has the following strengths: (1) the number of
participants is large and from the same population group and (2)
the diagnosis of diabetes was made using either fasting blood
glucose or an OGTT and compared.
However, our study also has some limitations: (1) the
haemoglobin and iron status was not determined simultaneously,
and these can affect the red blood cell survival and thus render
HbA1c levels unreliable; (2) the presence of renal impairment can
also affect HbA1c levels and was not investigated; (3) HbA1c levels
are affected by various haemoglobinopathies and thalassaemias
and these were not determined; (4) the extent to which
haemoglobin glycation occurs also varies between individuals
and may be affected by environmental parameters, such as lipid
peroxidation and hereditary factors, and (5) medication use,
specifically those such as antiretrovirals which may affect glucose
metabolism, was not examined Although we did not look for
haemoglobinopathies and thalassaemias, their incidence is fortu-
nately low in this population. Another possible shortcoming, but
not necessary limitation, of this study was that HbA1c was not
determined on an HPLC-based method as used in the DCCT and
may thus be more prone to interferences. However, the assay is
NGSP- certified and had acceptable CV’s.
In conclusion, we recommend an HbA1c value of 6.1%
(43 mmol/mol) as an optimal cut off to screen for diabetes in
our local population. A cut off of 6.5% (48 mmol/mol) would be a
good diagnostic tool with its high specificity (95% using fasting
blood glucose and 96% using OGTT), however the low sensitivity
limits the use of this value (50% using fasting blood glucose and
46% using OGTT).
Our study emphasizes the need for evidence based values to be
established in various population groups.
Methods
Ethical Considerations
The study was approved by the Cape Peninsula University of
Technology, Faculty of Health and Wellness Sciences Ethics
committee and the University of Stellenbosch Ethics committee
(N09/03/090). The study was conducted according to the
Declaration of Helsinki. All participants signed written informed
consent after all the procedures had been fully explained in the
language of their choice. In addition, permission was also sought
from other relevant authorities such as the city and community
authorities. These authorities granted permission to operate in the
community and also to make use of designated places such as
community halls or nearby schools for data and samples collection.
Patient confidentiality was maintained at all times.
Research Setting
Bellville-South is located within the Northern suburbs of Cape
Town, South Africa and is a traditionally a Coloured township
formed in the late 1950s. In the South African context, the term
township usually refers to the often underdeveloped urban living
areas that, under the Apartheid regime, were reserved for non-
whites. According to the 2001 population census, its population
stands at approximately 26 758 with 80.48% (21 536) consisting of
the Coloured (mixed race) [22]. The predominant language in this
community is Afrikaans and most of the residents of this
Table 2. Stratification of diabetic and normal subjects according to HbA1c cut-off of 6.5% and 6.1%.
HbA1c,6.5% HbA1c,6.1% HbA1c$6.5% HbA1c$6.1%
Diagnosis using FBG
Normal (%) 97.1 83.3 2.9 16.7
DM (%) 49.6 19.7 50.4 80.3
Diagnosis using OGTT
Normal (%) 97.5 80.5 2.5 19.5
DM (%) 54.1 24.7 45.9 75.3
doi:10.1371/journal.pone.0022558.t002
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community have lived there for over five years while others have
been there for their entire lives.
Research Design and Study Population
This was a cross-sectional quantitative study aimed at establishing
a cohort that can be followed up in randomly selected coloured
subject. The data was collected mid January 2008 to March 2009.
Using a map of Bellville South, multistage stratified random
sampling was approached as follows: From a list of streets from each
stratum, the streets were then classified as short, medium and long
streets based on the number of houses. Streets with houses #22
were classified as short, medium; houses 23–40 and long streets were
.40 houses. A total of 16 short streets representing approximately
190 houses, 15 medium streets representing approximately 410
houses and 12 long streets representing approximately 400 houses
were randomly selected across the different strata. From the selected
streets, all household members meeting the selection criteria were
invited to participate in the study.
Recruitment Strategy
Information regarding the project was disseminated to the local
residents through the local radio station, community news paper,
brochures and fliers; the latter bearing information about the
project and distributed through school children and taxis to the
local residents by the recruitment team. This team consisted of
unemployed matriculants and was managed by a qualified retired
nurse from the community. Recruited subjects were visited by the
recruitment team the evening before participation and reminded
of all the survey instructions. These included overnight fasting,
abstinence from drinking alcohol or consumption of any fluids in
the morning of participation. Furthermore, participants were
encouraged to bring along their medical/clinic cards and/or
medication they were currently using.
Pre-participation counseling
All participants except the self reported diabetic subjects, confirmed
by either medical card record or drugs in use, had blood taken for
fasting blood glucose and underwent a 75 g oral glucose tolerance test
(OGTT) as prescribed by the WHO. DM was diagnosed both
according to previous ADA criteria using only a fasting blood glucose
[3] and according to the WHO 2006 criteria [2] using a 75 g OGTT.
Blood samples were transported daily in an ice-pack box for
processing at an accredited laboratory. Plasma glucose was
measured by enzymatic hexokinase method (Cobas 6000, Roche
Diagnostics). HbA1c was assessed by turbidimetric inhibition
immunoassay (Cobas 6000, Roche Diagnostics). This method is
National Glycohemoglobin Standardization Programme (NGSP)
certified. The assay has a within-run CV of 1.4% and between run
CV of 2.8%.
Statistical Analysis
Statistical analysis of the data was performed using STATIS-
TICA (STATISTICA 9, StatSoft Inc 1984–2009). The continuous
variables are presented as median (confidence interval) or means6
standard deviation (SD), and categorical variable are expressed in
percentage. For data where the normality assumptions were suspect,
the Mann Whitney U test was used. Diabetes was diagnosed
according to bothWHO and ADA criteria; the ADA diagnostic cut-
off of 6.5% for HbA1c was tested separately for each group. A
Receiver operator characteristic (ROC) curve for both ADA and
WHOdiabetes criteria were generated and the area under the curve
(AUC) calculated. Test sensitivity, specificity positive predictive
value (ppv) and negative predictive value (npv) was calculated.
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